PGx Tools May Help Reassess Comparative Rx Effectiveness, PMC Official Tells Federal Council | GenomeWeb

Personalized medicine methods and technologies may help re-evaluate the comparative effectiveness of treatments, according to Amy Miller, policy director of the Personalized Medicine Coalition.

Miller, who made her comments at the first of three planned meetings of the Federal Coordinating Council for Comparative Effectiveness Research in Washington, DC, this week urged the council to "outline a plan by which comparative-effectiveness findings would be reconsidered."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.